CUTANEOUS MELANOMA, STAGE III
Clinical trials for CUTANEOUS MELANOMA, STAGE III explained in plain language.
Never miss a new study
Get alerted when new CUTANEOUS MELANOMA, STAGE III trials appear
Sign up with your email to follow new studies for CUTANEOUS MELANOMA, STAGE III, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New shot at melanoma: doctors test direct tumor injections to fight cancer
Disease control Recruiting nowThis study is testing a new approach for treating stage III melanoma that can be surgically removed. Researchers are injecting two immunotherapy drugs directly into the tumor before surgery, hoping this will be more effective and cause fewer body-wide side effects than standard I…
Matched conditions: CUTANEOUS MELANOMA, STAGE III
Phase: PHASE2 • Sponsor: UNICANCER • Aim: Disease control
Last updated Mar 27, 2026 12:37 UTC
-
Melanoma surgery trial: could less be just as good?
Disease control Recruiting nowThis study is testing if a smaller surgery is as good as the standard, larger surgery for people with stage III melanoma that has spread to lymph nodes. After 6 weeks of immunotherapy, participants will be randomly assigned to have either just the main affected lymph node removed…
Matched conditions: CUTANEOUS MELANOMA, STAGE III
Phase: NA • Sponsor: Melanoma Institute Australia • Aim: Disease control
Last updated Feb 24, 2026 14:05 UTC
-
Tracking the hidden toll of cancer breakthrough drugs
Knowledge-focused Recruiting nowThis study aims to understand the side effects that melanoma patients experience while receiving immunotherapy drugs. Researchers will follow 300 patients over time to track their symptoms, identify patterns, and learn what factors might make side effects worse. The goal is to ga…
Matched conditions: CUTANEOUS MELANOMA, STAGE III
Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Mar 16, 2026 15:24 UTC